September 29, 2016: Over the next two months, Danish company Novo Nordisk plans to lay off approximately 1,000 employees. Novo Nordisk, headquartered in Bagsvaerd, Denmark, employs about 42,300 people worldwide.
September 29, 2016: Shares of Arrowhead Pharma are up more than 18 percent to $8 per share in pre-market trading after Amgen bought a stake worth up to $675M in the company to develop and commercialize RNAi therapies for cardiovascular disease.
September 29, 2016: Genentech, licensed HM95573 from Seoul, South Korea-based Hanmi Pharmaceutical for a deal that could hit $910M.
September 29, 2016: Medigene and bluebird bio struck a collaborative deal to develop T cell receptor immunotherapies against four targets that could be worth more than $1B.